Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Agile Therapeutics Inc. AGRX

Alternate Symbol(s):  AGXRW

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.


Recent & Breaking News (NDAQ:AGRX)

AGILE THERAPEUTICS LOSS NOTICE: Rosen Law Firm Reminds Investors of Important Class Action Deadline – AGRX

Business Wire January 18, 2017

Lifshitz & Miller Law Firm Announces Investigation of Abeona Therapeutics Inc., Agile Therapeutics, Inc., Alere Inc., Floteck Industries, Inc., Insys Therapeutics Inc., MTS Systems Corporation, Ophthotech Corporation and Teekay Corporation

PR Newswire January 18, 2017

AGRX INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Agile Therapeutics, Inc. and a Lead Plaintiff Deadline of March 7, 2017

GlobeNewswire January 17, 2017

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire January 13, 2017

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In Agile Therapeutics, Inc. To Contact The Firm Before Lead Plaintiff Deadline

GlobeNewswire January 13, 2017

SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Agile Therapeutics, Inc. (AGRX) To Contact Brower Piven Before The Lead Plaintiff Deadline

GlobeNewswire January 12, 2017

Robbins Arroyo LLP: Agile Therapeutics, Inc. (AGRX) Misled Shareholders According to a Recently Filed Class Action

Business Wire January 11, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline: March 7, 2017

GlobeNewswire January 11, 2017

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Agile Therapeutics, Inc. (AGRX)

GlobeNewswire January 10, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Agile Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 7, 2017 – AGRX

GlobeNewswire January 10, 2017

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Agile Therapeutics, Inc.

Marketwired January 10, 2017

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces a Class Action Lawsuit Against Agile Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm

Business Wire January 10, 2017

The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Agile Therapeutics, Inc. Investors and Encourages Investors to Contact the Firm

Business Wire January 10, 2017

AGILE (AGRX) ALERT: Johnson & Weaver, LLP Announces Filing of Class Action Complaint Against Agile Therapeutics, Inc.; Encourages all Investors to Contact the Firm for Information

PR Newswire January 10, 2017

Harwood Feffer LLP Announces Investigation of Agile Therapeutics, Inc.

PR Newswire January 9, 2017

AGILE NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In Agile Therapeutics, Inc. To Contact The Firm

PR Newswire January 9, 2017

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Agile Therapeutics, Inc. – AGRX

Business Wire January 9, 2017

IMPORTANT AGILE THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP notifies investors that a securities class action lawsuit has been filed on behalf of shareholders of Agile Therapeutics, Inc. in the District of New Jersey -- AG

GlobeNewswire January 9, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline: March 7, 2017

PR Newswire January 9, 2017

Glancy Prongay & Murray LLP Files Securities Class Action Lawsuit Against Agile Therapeutics, Inc.

Business Wire January 6, 2017